STAGEZERO LIFE SCIENCES LTD.

Profile

Company Names

STAGEZERO LIFE SCIENCES LTD.
GENENEWS LTD

Addresses

70 EAST BEAVER CREEK RD, UNIT 30, RICHMOND HILL, A6 L4B 3B2

70 EAST BEAVER CREEK ROAD, UNIT 30, RICHMOND HILL, A6 L4B 3B2

70 EAST BEAVER CREEK ROAD, SUITE 30, RICHMOND HILL, A6 L4B 3B2

30 - 70 EAST BEAVER CREEK RD., RICHMOND HILL, A6 L4B 3B2

445 APPLE CREEK BLVD., SUITE 220, MARKHAM, A6 L3R 9X7

2 EAST BEAVER CREEK ROAD, BUILDING 2, RICHMOND HILL, A6 L4B 2N3

Phone Numbers

905-209-2030
(905)209-2030
1 905-209-2030
1 (905) 739-2030

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER

Year Incorporated:

> 5 years ago

State Incorporated:

ONTARIO, CANADA

Total Amount Raised:

$27,261,548.00

Number of Funding Rounds:

14
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
14
2022-03-02 
$1,476,161.00 
$3,217,557.00 
$1,741,396.00 
Equity 
13
2021-11-26 
$3,288,702.00 
$7,399,579.00 
$4,110,877.00 
Equity 
12
2020-12-04 
$198,309.00 
$338,143.00 
$139,834.00 
Equity 
11
2020-02-19 
$113,371.00 
$113,448.00 
$77.00 
Equity 
10
2018-06-07 
$1,541,783.00 
$2,543,212.00 
$1,001,429.00 
Equity, Debt 
9
2018-05-22 
$852,219.00 
$1,581,103.00 
$728,884.00 
Equity 
8
2017-07-14 
$245,558.00 
$245,558.00 
$0.00 
Equity 
7
2016-03-31 
$370,435.00 
INDEFINITE 
INDEFINITE 
Equity 
6
2014-07-07 
$5,971,000.00 
$7,210,000.00 
$1,239,000.00 
Equity 
5
2012-12-14 
$6,303,211.00 
$6,303,211.00 
$0.00 
Equity 
4
2011-06-09 
$5,273,385.00 
$5,273,385.00 
$0.00 
Equity 
3
2010-11-12 
$1,354,526.00 
$1,354,526.00 
$0.00 
Equity, Debt 
2
2009-12-21 
$100,808.00 
$100,808.00 
$0.00 
Equity 
1
2009-07-09 
$172,080.00 
$172,080.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LESLIE 
 
AULD 
EXECUTIVE OFFICER, DIRECTOR
GENENEWS LTD   |  AETERNA ZENTARIS INC.
FLOYD 
C. 
DENT III 
DIRECTOR
GENENEWS LTD
HEINER 
 
DREISMANN 
DIRECTOR, EXECUTIVE OFFICER
GENENEWS LTD   |  STRATOS GENOMICS INC.   |  SINGULEX INC   |  HISTORX INC   |  SINGULEX, INC.   |  ADARZA BIOSYSTEMS, INC.   |  ADVANDX, INC.   |  GESTVISION, INC.   |  IXCELA, INC.   |  MOBILION SYSTEMS, INC.   |  MAINZ BIOMED N.V.
HARRY 
 
GLORIKAN 
DIRECTOR
STAGEZERO LIFE SCIENCES LTD.
HARRY 
 
GLORIKIAN 
DIRECTOR
GENENEWS LTD   |  MEDPANEL, LLC   |  STAGEZERO LIFE SCIENCES LTD.
HARRY 
A 
GLORIKIAN 
DIRECTOR
GENENEWS LTD
JAMES 
 
HOWARD-TRIPP 
EXECUTIVE OFFICER, DIRECTOR
GENENEWS LTD
JAMES 
R. 
HOWARD-TRIPP 
EXECUTIVE OFFICER, DIRECTOR
GENENEWS LTD   |  STAGEZERO LIFE SCIENCES LTD.
RICHARD 
JANICE 
HUSTON 
DIRECTOR
STAGEZERO LIFE SCIENCES LTD.
CHOON-CHIN 
 
LIEW 
EXECUTIVE OFFICER, DIRECTOR
GENENEWS LTD
GAILINA 
 
LIEW 
EXECUTIVE OFFICER, DIRECTOR
GENENEWS LTD
GARTH 
 
MACRAE 
DIRECTOR
GENENEWS LTD   |  URANIUM PARTICIPATION CORP   |  STAGEZERO LIFE SCIENCES LTD.
GARTH 
C. 
MACRAE 
DIRECTOR
GENENEWS LTD
K 
WAYNE 
MARSHALL 
EXECUTIVE OFFICER, DIRECTOR
GENENEWS LTD
GARTH 
 
MCRAE 
DIRECTOR
GENENEWS LTD
RORY 
 
RIGGS 
DIRECTOR
GENENEWS LTD   |  CIBUS GLOBAL, LTD.   |  LOCUS INVESTMENT FUND I, L.P.   |  COH INC.   |  RPI INTERNATIONAL HOLDINGS, LP   |  LOCUS 900 I, LP   |  LOCUS GLOBAL I, LP   |  SYNTAX 900 I, LP   |  ERECEIVABLES INC.   |  SYNTAX INDEX SERIES LP   |  SYNTAX GLOBAL I, LP   |  RPS BIOPHARMA HOLDINGS, LP   |  RPS BIOPHARMA INVESTMENTS, LP   |  STAGEZERO LIFE SCIENCES LTD.
DAVID 
 
SABLE 
DIRECTOR
GENENEWS LTD   |  AMERICAN EAGLE OUTFITTERS INC   |  HAMILTON THORNE LTD.   |  LIFE SCIENCES INNOVATION FUND L.P.   |  LIFE SCIENCES INNOVATION FUND II, L.P.   |  AUTOIVF, INC.
CARL 
 
SOLOMON 
EXECUTIVE OFFICER
STAGEZERO LIFE SCIENCES LTD.
THOMAS 
 
STEWART JR. 
DIRECTOR
GENENEWS LTD
THOMAS 
D. 
STEWART, JR. 
DIRECTOR
GENENEWS LTD
FRAN 
 
TUTTLE 
DIRECTOR
GENENEWS LTD   |  GLUMETRICS INC
KARL 
 
WASSMANN 
EXECUTIVE OFFICER
SOURCE PRECISION MEDICINE, INC.   |  GENENEWS LTD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-03-17
D
Link
BIOTECHNOLOGY 
 
$5,000,001 - $25,000,000 
Equity 
2022-03-02 
2022-02-07
D/A
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2021-11-26 
2022-01-04
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2021-11-26 
2020-12-18
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2020-12-04 
2020-06-23
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2020-02-19 
2018-06-22
D
Link
OTHER 
 
$1 - $1,000,000 
Equity, Debt 
2018-06-07 
2018-06-06
D
Link
OTHER 
 
$1 - $1,000,000 
Equity 
2018-05-22 
2017-07-31
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2017-07-14 
2016-04-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-31 
2014-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-07 
2012-12-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-14 
2011-06-23
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2011-06-09 
2010-11-26
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity, Debt 
2010-11-12 
2009-12-31
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-12-21 
2009-07-23
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2009-07-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375